HISTORY OF PRESENT ILLNESS:  The patient is a 68 year old white male with known coronary artery disease, CABG and [**Last Name (un) 1291**] in [**2177**], diabetes, hypertension, end stage renal disease status post renal transplant in [**2179**], who had excision of the left fifth met head on [**2181-10-25**] by Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 52130**] of the podiatry service.
Cultures then grew two species of Enterococcus which were sensitive to ampicillin, penicillin, vancomycin and resistant to Levaquin.
Cultures were taken and the patient was started on linezolid 600 mg b.i.d.
and Levaquin 500 q.d.
Penicillin causes a rash.
End stage renal disease secondary to IV contrast.
The patient was put on hemodialysis post CABG for 11 months and then underwent transplant from his wife.
Renal transplant in [**2179**] at [**State 792**]Hospital.
MEDICATIONS ON ADMISSION:  Zyvox 600 mg b.i.d.
; Levaquin 500 mg q.d.
; Coumadin 10 mg Monday, Tuesday, Wednesday, Thursday, 7.5 Friday, Saturday, Sunday; prednisone 5 mg q.d.
; Gengraf 75 mg b.i.d.
; Rapamune 5 mg q.d.
; multivitamin tablet q.d.
; NPH insulin 20 units q.a.m.
and 18 units in the evening; Lopressor 50 mg b.i.d.
; Avapro 300 mg q.d.
; Pravachol 40 q.d.
; gemfibrozil 600 mg b.i.d., Regranex ulcer wound care.
The patient underwent a thallium stress at an outside hospital on [**2181-6-11**] which showed no ischemic defects.
The patient was begun on levo, Flagyl and vancomycin antibiotics.
The patient's Coumadin was held when his INR was less than 2.5 and heparinization was begun for a 40 to 60.
The patient was rehydrated and Mucomyst protocol was instituted.
He underwent surgery on [**2182-2-12**].
He underwent left SFA/DP bypass with greater saphenous and brachial [**Date Range 5703**] graft.
He tolerated the procedure well and was transferred to the PACU in stable condition.
Postoperatively he required one unit of packed red blood cells in the PACU for hematocrit of 29.4.
The patient did require overnight, because of low urinary output, a fluid bolus to maintain his urinary output.
On postoperative day one he was continued on morphine sulfate for analgesic control.
His preoperative medications were reinstituted.
He continued on IV heparin and coumadinization was begun.
The patient was continued on his antibiotics.
On postoperative day two he still required fluid boluses for low urinary output.
Hematocrit post transfusion was 28.1.
On [**2182-2-14**] the patient underwent resection of the fifth metatarsal head on the left.
He tolerated the procedure well.
The day after his podiatry procedure his central line was discontinued.
After two more units of packed red blood cells the patient's hematocrit was 30.0.
The patient's vancomycin was discontinued on [**2182-2-15**].
His Foley and central line were discontinued on [**2182-2-17**].
At the time of discharge recommendations were for a total of four more weeks from [**2182-2-17**] of antibiotics with linezolid.
CBC should be monitored at days 10 and 20 of his antibiotics to insure there are no bone marrow effects.
Prednisone 5 mg q.d.
Sirolimus 5 mg q.d.
Pravastatin 40 mg q.d.
Gemfibrozil 600 mg b.i.d.
Acetaminophen 325 to 650 mg q.four to six hours p.r.n.. 6.
Colace 100 mg b.i.d.
Bisacodyl 10 mg p.r.
Pentamidine 20 mg q.d.
Nitroglycerin 0.5 mg sublingual for a total of three doses q.five minutes, if no relief to call physician.
Nystatin ointment to the penis and foreskin b.i.d.
Cyclosporine modified (Neoral) 75 mg q.12 hours.
Metoprolol 100 mg t.i.d., hold for systolic blood pressure less than 100, heart rate less than 55.
Aluminum magnesium hydroxide 15 to 30 cc q.i.d.
Avapro 300 mg q.d.
Nitroglycerin 2 percent 0.5 inches topical q.six hours p.r.n.
Warfarin 10 mg on Monday, Tuesday, Wednesday, Friday; 7.5 mg on Sunday, Thursday, Saturday.
Linezolid 600 mg q.12 hours.
Enterococcal foot infection status post debridement with resection of fifth met head.
Ischemic ulceration with SFA tibial disease status post angio status post left SFA to BP bypass with greater saphenous and basilic [**Telephone/Fax (1) 5703**] composite graft.
Status post renal transplant immunosuppressed, stable.
